FIRST AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • October 27th, 2015 • Cryolife Inc • Surgical & medical instruments & apparatus • New York
THIS FIRST AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT (“Amendment”) is entered into as of September 28, 2015, by and among CryoLife, Inc. (“CryoLife”), CryoLife International, Inc. (“International”) and Aurazyme Pharmaceuticals, Inc. (“Auruzyme”, and together with CryoLife and International, the “Borrowers”), CryoLife as Borrower Representative, the other Credit Parties party hereto, General Electric Capital Corporation, a Delaware corporation (the “Agent”), as administrative agent for the lenders from time to time party to the Credit Agreement described below (collectively, the “Lenders” and individually each a “Lender”) and for itself as a Lender and L/C Issuer, and such Lenders.
SEPARATION AND RELEASE AGREEMENTSeparation and Release Agreement • October 27th, 2015 • Cryolife Inc • Surgical & medical instruments & apparatus • Georgia
In consideration of the promises and mutual undertakings contained herein, and other good and valuable consideration, the receipt and sufficiency of which the parties hereby acknowledge, the parties to this Separation and Release Agreement (the “Agreement”), Bruce G. Anderson (“Employee”) and CryoLife, Inc. (“CryoLife” or the “Company”), hereby agree as follows:
SEPARATION AND RELEASE AGREEMENTSeparation and Release Agreement • October 27th, 2015 • Cryolife Inc • Surgical & medical instruments & apparatus • Georgia
In consideration of the promises and mutual undertakings contained herein, and other good and valuable consideration, the receipt and sufficiency of which the parties hereby acknowledge, the parties to this Separation and Release Agreement (the “Agreement”), David M. Fronk (“Employee”) and CryoLife, Inc. (“CryoLife” or the “Company”), hereby agree as follows:
